The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kalinina M.I.

Belgorod National Research University

Ponomarenko I.V.

Belgorod State National Research University

Efremova O.A.

Belgorod State National Research University

Batlutskaya I.V.

Belgorod State National Research University

Churnosov M.I.

Belgorod State National Research University

The role of gene-gene and gene-environmental interactions of polymorphic matrix metalloproteinases loci in the formation of the risk of stroke in men with hypertension

Authors:

Kalinina M.I., Ponomarenko I.V., Efremova O.A., Batlutskaya I.V., Churnosov M.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8‑2): 41‑47

DOI: 10.17116/jnevro202212208241

Read: 2087 times

Download PDF (RU)
Contact the author
Table of contents

THE ROLE OF GENE-GENE AND GENE-ENVIRONMENTAL INTERACTIONS OF POLYMORPHIC MATRIX METALLOPROTEINASES LOCI IN THE FORMATION OF THE RISK OF STROKE IN MEN WITH HYPERTENSION
THE ROLE OF GENE-GENE AND GENE-ENVIRONMENTAL INTERACTIONS OF POLYMORPHIC MATRIX METALLOPROTEINASES LOCI IN THE FORMATION OF THE RISK OF STROKE IN MEN WITH HYPERTENSION

To cite this article:

Kalinina MI, Ponomarenko IV, Efremova OA, Batlutskaya IV, Churnosov MI. The role of gene-gene and gene-environmental interactions of polymorphic matrix metalloproteinases loci in the formation of the risk of stroke in men with hypertension. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8‑2):41‑47. (In Russ.)
https://doi.org/10.17116/jnevro202212208241

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Early anti­thrombotic protection of the brain in patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):5-10
Resu­lts of the implementation of repe­rfusion technologies in ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):32-39
Resu­lts of the inte­rnational multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the effi­cacy and safety of the sequential therapy with ethy­lmethylhydroxypyridine succinate in patients in the acute and early reco­very periods of ischemic stroke (MIR). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):40-53
Role of magnetic reso­nance imaging in dete­cting the signs of inte­rnal caro­tid artery stenosis in the acute period of athe­rothrombotic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):67-73
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
Socio-economic damage caused by elevated low-density lipo­protein cholesterol levels. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):88-98
Cere­brolysin with repe­rfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CERE­HETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):84-98
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127
Asse­ssment of biomarker levels in patients with STEMI, depe­nding on the presence of cardiovascular events. Russian Journal of Preventive Medi­cine. 2025;(8):96-101
A clinical case of treating a patient with severe ischemic stroke and cancer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):114-117
Abstract:

OBJECTIVE

Analysis of the role of genetic polymorphisms of matrix metalloproteinases (MMPs), their gene-gene and gene-environment interactions in the formation of ischemic stroke in men with arterial hypertension (AI).

MATERIAL AND METHODS

The study included 523 men with arterial hypertension: 201 patients with ischemic stroke and 322 patients without stroke. The association of MMPs loci with stroke with hypertension was determined by logistic regression analysis in dominant, recessive, additive genetic models in PLINK v.2.050. For five SNPs co-located on chromosome 11 (314.3 kb), haplotypic analysis was performed, the relationship of haplotypes with stroke development was determined by the EM algorithm. Gene-gene and gene-environment interactions of MMPs with smoking and alcohol consumption during stroke development were evaluated by GMDR (Generalized Multifactor Dimensionality Reduction) using GMDR v.0.9 software.

RESULTS

Polymorphic locus rs3025058 is associated with stroke in men in dominant and additive genetic models (OR=0.63—0.74, pperm=0.03). Four haplotypes of MMPs have a protective effect on the development of stroke with hypertension (OR=0.48—0.50, pperm=0.02—0.03). Four models of gene-gene interactions of polymorphic MMPs loci (OR=2.19—2.55, pperm<0.001) and three four-factor models of gene-environment interactions of MMPs with alcohol abuse (OR=2.82—3.11, pperm<0.001) are associated with a high risk of ischemic stroke in men with hypertension. rs3025058, rs1320632, rs11225395 and rs1799750 demonstrate the greatest contribution to gene-gene and gene-environment interactions in the formation of AI.

CONCLUSION

Thus, the results of the study indicate that the interactions of MMPs genes with each other and with modifiable environmental factors play a significant role in the development of stroke with hypertension in men.

Keywords:

ischemic stroke
matrix metalloproteinases
gene-environment interactions

Authors:

Kalinina M.I.

Belgorod National Research University

Ponomarenko I.V.

Belgorod State National Research University

Efremova O.A.

Belgorod State National Research University

Batlutskaya I.V.

Belgorod State National Research University

Churnosov M.I.

Belgorod State National Research University

Received:

02.02.2022

Accepted:

02.02.2022

Close metadata

References:

  1. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21(4):637-676.  https://doi.org/10.1161/01.str.21.4.637
  2. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics — 2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292. https://doi.org/10.1161/01.cir.0000441139.02102.80
  3. Madsen TE, Khoury J, Alwell K, et al. Sex-specific stroke incidence over time in the Greater Cincinnati/Northern Kentucky Stroke Study. Neurology. 2017;89(10):990-996.  https://doi.org/10.1212/WNL.0000000000004325
  4. Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group. Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015;45(3):203-214.  https://doi.org/10.1159/000441103
  5. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572. https://doi.org/10.1001/jama.289.19.2560
  6. Polonikov AV, Ushachev DV, Ivanov VP, et al. Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis. Journal of Hypertension. 2015;33(11):2265-2277. https://doi.org/10.1097/HJH.0000000000000699
  7. Moskalenko M, Ponomarenko I, Reshetnikov E, et al. Polymorphisms of the matrix metalloproteinase genes are associated with essential hypertension in a Caucasian population of Central Russia. Scientific Reports. 2021;11(1):5224. https://doi.org/10.1038/s41598-021-84645-4
  8. Moskalenko MI, Ponomarenko IV, Polonikov AV, et al. The role of the stress factor in the realization of the genetic predisposition to the development of stroke in patients with essential hypertension. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(3 vyp 2):11-17. (In Russ.). https://doi.org/10.17116/jnevro201911903211
  9. Gori AM, Giusti B, Piccardi B. Inflammatoryandmetalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis. Journal of Cerebral Blood Flow and Metabolism. 2017;37(9):3253-3261. https://doi.org/10.1177/0271678X17695572
  10. Müller A, Krämer SD, Meletta R, et al. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Nucl Med Biol. 2014;41(7):562-569.  https://doi.org/10.1016/j.nucmedbio.2014.04.085
  11. Montaner J, Ramiro L, Simats A, et al. Matrix metalloproteinases and ADAMs in stroke. Cell Mol Life Sci. 2019;76(16):3117-3140. https://doi.org/10.1007/s00018-019-03175-5
  12. Britov AN, Pozdnyakov YM. Cardiovascular prevention. National recommendations. VNOK. Cardiovascular Therapy Prevention. 2011;10(6):57. (In Russ.). ISSN: 1728-8800.
  13. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and Diagnosis of Pulmonary Hypertension. Journal of the American College of Cardiology. 2013;62(25):42-50.  https://doi.org/10.1016/j.jacc.2013.10.032
  14. Moskalenko MI. The involvement of genes of matrix metalloproteinases in the development of arteial hypertension and its complication (review). Research Result. Medicine and Pharmacy. 2018;4(1):53-69. (In Russ.). https://doi.org/10.18413/2313-8955-2018-4-1-53-69
  15. Polonikov AV, Klyosova EYu, Azarova IE. Bioinformatic tools and internet resources for functional annotation of polymorphic loci detected by genome wide association studies of multifactorial diseases (review). Research Results in Biomedicine. 2021;7(1):15-31. (In Russ.). https://doi.org/10.18413/2658-6533-2020-7-1-0-2
  16. Rivera S, Khrestchatisky M, Kaczmarek L, et al. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci. 2010;30(46):15337-15357. https://doi.org/10.1523/JNEUROSCI.3467-10.2010
  17. Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J Neurochem. 2016;139(suppl 2):91-114.  https://doi.org/10.1111/jnc.13415
  18. Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis. 2010;38:376-385.  https://doi.org/10.1016/j.nbd.2010.03.008
  19. Moskalenko MI, Ponomarenko IV, Verzilina IN, et al. The role of gene-gene and geneenvironment interactions of polymorphic locuses of MMPs in the formation of hypertension in women. Arterial’naya Gipertenziya = Arterial Hypertension. 2020;26(5):518-525. (In Russ.). https://doi.org/10.18705/1607-419X-2020-26-5-518-525
  20. Zhang G, Li W, Guo Y, et al. MMP Gene Polymorphisms, MMP-1-1607 1G/2G, -519 A/G, and MMP-12-82 A/G, and Ischemic Stroke: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2018;27(1):140-152.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.021
  21. Ghilardi G, Biondi ML, DeMonti M, et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke. 2002;33(10):2408-2412. https://doi.org/10.1161/01.str.0000031929.05665.da
  22. Sherva R, Ford CE, Eckfeldt JH, et al. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: The GenHAT Study. Stroke; a Journal of Cerebral Circulation. 2011;42(2):34-38.  https://doi.org/10.1161/STROKEAHA.110.593798
  23. Zhang QW. Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis. Neuropsychiatr Dis Treat. 2018;14:419-427.  https://doi.org/10.2147/NDT.S152256
  24. Polonikov AV, Ponomarenko IV, Bykanova MA, et al. A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk. Hypertens Res. 2019;42(2):257-272.  https://doi.org/10.1038/s41440-018-0142-1
  25. Polonikov, A, Rymarova, L, Klyosova, E, et al. Matrix metalloproteinases as target genes for gene regulatory networks driving molecular and cellular pathways related to a multistep pathogenesis of cerebrovascular disease. J Cell Biochem. 2019;120:16467-16482. https://doi.org/10.1002/jcb.28815
  26. Zhao JH, Xu YM, Xing HX. Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction. Genet Mol Res. 2016;14(4):19418-19424. https://doi.org/10.4238/2015.December.30.3
  27. Clee SM. A role for MMP-3 genetic variation in atherosclerosis susceptibility? Atherosclerosis. 2010;208:30-31.  https://doi.org/10.1016/j.atherosclerosis.2009.09.019
  28. Hsieh FI, Chiou HY, Hu CJ, et al. Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke. J Clin Med. 2019;8(11):2011. https://doi.org/10.3390/jcm8112011
  29. Chehaibi K, Hrira MY, Nouira S, et al. Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population. J Neurol Sci. 2014;342:107-113.  https://doi.org/10.1016/j.jns.2014.04.036
  30. Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289(5):579-588.  https://doi.org/10.1001/jama.289.5.579
  31. Liu J, Khalil RA. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. Prog Mol Biol Transl Sci. 2017;148:355-420.  https://doi.org/10.1016/bs.pmbts.2017.04.003
  32. Osipova OA, Gosteva EV, Belousova ON, et al. Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers. Cardiovascular Therapy and Prevention. 2021;20(8):3087. (In Russ.). https://doi.org/10.15829/1728-8800-2021-3087
  33. Haorah J, Schall K, Ramirez SH, et al. Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: Novel mechanism for neurodegeneration associated with alcohol abuse. Glia. 2008;56(1):78-88.  https://doi.org/10.1002/glia.20596
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.